GLYC Insider Trading

Insider Trading Chart
Insider Trading History
Frequently Asked Questions
About

Notice: This stock is marked as potentially delisted. It may not be actively trading.

Insider Ownership Percentage: 8.70%

Insider Buying (Last 12 Months): $0.00

Insider Selling (Last 12 Months): $0.00

GlycoMimetics Insider Trading History Chart

GlycoMimetics Share Price & Price History

^$0.16

▼ -0.011 (-6.63%)

As of 06/13/2025 08:49 PM ET

GlycoMimetics Insider Trading History

Transaction Date	Insider Name	Title	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
8/7/2024	Public Equities L.P. Invus	Major Shareholder	Sell	614	$18.00	$11,052.00	65,784
8/5/2024	Public Equities L.P. Invus	Major Shareholder	Sell	1,645	$19.00	$31,255.00	66,956
8/1/2024	Public Equities L.P. Invus	Major Shareholder	Sell	635	$22.00	$13,970.00	71,463
7/29/2024	Public Equities L.P. Invus	Major Shareholder	Sell	3,639	$24.00	$87,336.00	79,667
7/26/2024	Public Equities L.P. Invus	Major Shareholder	Sell	2,583	$24.00	$61,992.00	83,307
6/20/2024	Edwin Rock	Insider	Buy	1,900	$25.00	$47,500.00	5,654
9/21/2023	Edwin Rock	Insider	Buy	350	$138.00	$48,300.00	3,450
5/17/2023	Brian M Hahn	CFO	Sell	37	$195.00	$7,215.00	531
5/10/2023	Daniel M Junius	Director	Buy	300	$156.00	$46,800.00	932
5/8/2023	Bruce S Johnson	SVP	Buy	135	$157.00	$21,195.00	1,389
2/23/2023	Public Equities L.P. Invus	Major Shareholder	Buy	2,000	$175.00	$350,000.00	84,890
2/21/2023	Public Equities L.P. Invus	Major Shareholder	Buy	500	$185.00	$92,500.00	81,390
2/17/2023	Public Equities L.P. Invus	Major Shareholder	Buy	2,000	$171.00	$342,000.00	80,890
2/15/2023	Public Equities L.P. Invus	Major Shareholder	Buy	10,000	$216.00	$2,160,000.00	75,737
2/9/2023	Public Equities L.P. Invus	Major Shareholder	Buy	114	$324.00	$36,936.00	65,737
1/25/2023	Scott D Sandell	Major Shareholder	Sell	6,520	$326.00	$2,125,520.00	35,882
1/5/2023	Scott D Sandell	Major Shareholder	Sell	713	$276.00	$196,788.00	38,819
1/3/2023	Scott D Sandell	Major Shareholder	Sell	1,748	$299.00	$522,652.00	39,600
12/22/2022	Edwin Rock	Insider	Buy	1,100	$225.00	$247,500.00	3,100

SEC Filings (Institutional Ownership Changes) for GlycoMimetics (NASDAQ:GLYC)

75.19% of GlycoMimetics stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

GlycoMimetics Institutional Trading History

Reporting Date	Hedge Fund	Shares Held	Market Value	% of Portfolio	Quarterly Change in Shares	Ownership in Company
5/14/2025	Wellington Management Group LLP	1,370,297	$0.29M	0.0%	-3.0%	2.124%
5/8/2025	Jefferies Financial Group Inc.	585,000	$0.12M	0.0%	+38.0%	0.907%
3/24/2025	Wellington Management Group LLP	1,413,402	$0.35M	0.0%	N/A	2.191%
2/27/2025	Jefferies Financial Group Inc.	423,777	$0.11M	0.0%	N/A	0.657%
2/17/2025	VR Adviser LLC	3,000,000	$0.75M	0.1%	N/A	4.653%
2/17/2025	Jefferies Financial Group Inc.	423,777	$0.11M	0.0%	N/A	0.657%
2/17/2025	Caxton Corp	203,578	$51K	0.3%	N/A	0.316%
2/14/2025	Adage Capital Partners GP L.L.C.	5,091,231	$1.27M	0.0%	N/A	7.896%
2/13/2025	ADAR1 Capital Management LLC	331,827	$83K	0.0%	+626.1%	0.515%
2/12/2025	Wellington Management Group LLP	1,413,402	$0.35M	0.0%	N/A	2.192%
8/9/2024	Renaissance Technologies LLC	826,851	$0.23M	0.0%	+483.5%	1.283%
8/6/2024	Acadian Asset Management LLC	534,753	$0.15M	0.0%	+61.8%	0.830%
5/15/2024	NEA Management Company LLC	3,835,039	$11.51M	0.7%	-19.5%	5.949%
5/10/2024	Acadian Asset Management LLC	330,526	$0.99M	0.0%	-38.9%	0.513%
5/10/2024	Vanguard Group Inc.	2,761,981	$8.29M	0.0%	+14.0%	4.285%
2/8/2024	Advisor OS LLC	101,000	$0.24M	0.0%	N/A	0.157%
2/5/2024	Intellectus Partners LLC	50,720	$0.12M	0.0%	-18.2%	0.079%
1/18/2024	MJP Associates Inc. ADV	101,000	$0.24M	0.1%	N/A	0.157%
11/15/2023	Acuta Capital Partners LLC	27,500	$41K	0.0%	N/A	0.043%
11/13/2023	Acadian Asset Management LLC	844,051	$1.27M	0.0%	-26.6%	1.311%
11/13/2023	Sargent Investment Group LLC	58,000	$87K	0.0%	-46.3%	0.090%
10/25/2023	Intellectus Partners LLC	61,975	$93K	0.0%	-15.7%	0.096%
8/7/2023	Acadian Asset Management LLC	1,149,656	$2M	0.0%	-18.0%	1.788%
7/31/2023	Intellectus Partners LLC	73,475	$0.13M	0.0%	-10.1%	0.114%
7/18/2023	Stratos Wealth Partners LTD.	33,340	$58K	0.0%	-67.5%	0.052%
5/11/2023	Letko Brosseau & Associates Inc.	45,250	$57K	0.0%	N/A	0.070%
5/11/2023	Acadian Asset Management LLC	1,401,653	$1.77M	0.0%	-27.9%	2.182%
5/10/2023	Beirne Wealth Consulting Services LLC	50,000	$63K	0.0%	+25.0%	0.078%
5/10/2023	Connor Clark & Lunn Investment Management Ltd.	159,001	$0.20M	0.0%	+143.5%	0.247%
5/5/2023	Truist Financial Corp	101,000	$0.13M	0.0%	N/A	0.157%
5/2/2023	Sargent Investment Group LLC	108,000	$0.14M	0.0%	N/A	0.168%
4/27/2023	Stratos Wealth Partners LTD.	102,565	$0.13M	0.0%	N/A	0.160%
4/26/2023	Chicago Partners Investment Group LLC	20,000	$28K	0.0%	N/A	0.031%
2/15/2023	Freedom Wealth Alliance LLC	9,452	$29K	0.0%	N/A	0.018%
2/10/2023	NEA Management Company LLC	8,967,706	$27.17M	1.5%	-1.3%	17.107%
2/10/2023	Connor Clark & Lunn Investment Management Ltd.	65,288	$0.20M	0.0%	N/A	0.125%
2/8/2023	Beirne Wealth Consulting Services LLC	40,000	$0.12M	0.1%	N/A	0.076%
2/2/2023	Intellectus Partners LLC	81,730	$0.25M	0.1%	-32.2%	0.156%
1/31/2023	AE Wealth Management LLC	26,898	$82K	0.0%	N/A	0.051%
5/12/2022	Acadian Asset Management LLC	1,990,087	$2.27M	0.0%	+2.0%	3.798%
5/12/2022	Connor Clark & Lunn Investment Management Ltd.	89,926	$0.10M	0.0%	-24.7%	0.172%
2/14/2022	Eversept Partners LP	100,000	$0.14M	0.0%	N/A	0.193%
2/14/2022	GSA Capital Partners LLP	146,078	$0.21M	0.0%	N/A	0.282%
2/10/2022	Acadian Asset Management LLC	1,951,086	$2.81M	0.0%	+3.4%	3.771%
11/16/2021	Two Sigma Advisers LP	621,000	$1.36M	0.0%	-12.4%	1.200%
11/16/2021	Two Sigma Investments LP	498,530	$1.09M	0.0%	+121.0%	0.964%
11/15/2021	Dimensional Fund Advisors LP	904,628	$1.98M	0.0%	-23.3%	1.748%
11/15/2021	Franklin Resources Inc.	160,700	$0.35M	0.0%	N/A	0.311%
11/12/2021	Renaissance Technologies LLC	596,100	$1.31M	0.0%	-21.3%	1.152%
11/12/2021	Connor Clark & Lunn Investment Management Ltd.	112,298	$0.25M	0.0%	+5.5%	0.217%
11/9/2021	BlackRock Inc.	875,151	$1.92M	0.0%	-1.2%	1.691%
8/17/2021	Millennium Management LLC	686,577	$1.59M	0.0%	+1,284.5%	1.332%
8/16/2021	State Street Corp	144,265	$0.34M	0.0%	-77.9%	0.280%
8/16/2021	Goldman Sachs Group Inc.	123,407	$0.29M	0.0%	+253.3%	0.239%

Data available starting January 2016

GlycoMimetics, Inc., a biotechnology company, focuses on the discovery and development of therapies for cancers and inflammatory diseases in the United States. It develops uproleselan, an E-selectin antagonist, which is used in combination with chemotherapy to treat acute myeloid leukemia (AML), as well as completed phase 3 trial to treat relapsed/refractory AML. The company also develops various other programs, including GMI-1687, an antagonist of E-selectin to treat vaso-occlusive crisis; and GMI-2093, a galectin-3 carbohydrate-binding protein. In addition, its portfolio comprises GMI-1359, which targets e-selectin and a chemokine receptor for the treatment of osteosarcoma. The company has a cooperative research and development agreement with the National Cancer Institute; and a collaboration and license agreement with Apollomics (Hong Kong) Limited for the development and commercialization of uproleselan and GMI-1687. GlycoMimetics, Inc. was incorporated in 2003 and is headquartered in Rockville, Maryland.

Today's Range

Now: $0.16

$0.15

$0.17

50 Day Range

MA: $13.48

$0.16

$27.47

52 Week Range

Now: $0.16

$14.06

$63.00

Volume

1,049,686 shs

Average Volume

67,672 shs

Market Capitalization

$10.00 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

1.62

Who are the company insiders with the largest holdings of GlycoMimetics?: GlycoMimetics' top insider shareholders include:
Public Equities LP Invus (Major Shareholder)
Edwin Rock (Insider)
Learn More about top insider investors at GlycoMimetics.